EUDRAGIT® based amorphous solid dispersions (ASD) for smart solubility enhancement solutions
- WHEN: Wednesday, May 20 | 9:55 - 10:25 a.m
- WHERE: Room 1
- WHO: Dr. Maria Montero Mirabet (Global Product Manager Lipids) | Evonik Health Care)
Be sure to catch the presentation on EUDRAGIT®-based amorphous solid dispersions (ASD) for smart solubility enhancement by our expert Maria Montero Mirabet. In her talk, you will learn how ASD technology can significantly improve the bioavailability of poorly soluble drugs by maintaining them in a stabilized amorphous state. The session will highlight how EUDRAGIT® polymers enable controlled release and prevent recrystallization, as well as showcase formulation strategies such as spray drying and hot melt extrusion. In addition, real-world examples and data will demonstrate how this approach helps overcome solubility challenges while enabling robust and scalable pharmaceutical development.